These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 21766503)

  • 1. Conventional versus virtual simulation for radiation treatment planning of prostate cancer: final results.
    Kantzou I; Platoni K; Sandilos P; Gouliamos A; Kouvaris I; Sarris G; Kelekis N; Kouloulias V
    J BUON; 2011; 16(2):309-15. PubMed ID: 21766503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of conventional and virtual simulation for radiation treatment planning of prostate cancer.
    Kantzou I; Kelekis N; Platoni K; Sandilos P; Gouliamos A; Kouvaris I; Kouloulias V
    J BUON; 2010; 15(4):684-9. PubMed ID: 21229630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes.
    Hsu A; Pawlicki T; Luxton G; Hara W; King CR
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):898-902. PubMed ID: 17459610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of IMRT to cover pelvic nodes while escalating the dose to the prostate gland: dosimetric data on 35 consecutive patients.
    Bayouth JE; Pena J; Culp L; Brack C; Sanguineti G
    Med Dosim; 2008; 33(3):180-90. PubMed ID: 18674682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
    Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
    Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boost first, eliminate systematic error, and individualize CTV to PTV margin when treating lymph nodes in high-risk prostate cancer.
    Rossi PJ; Schreibmann E; Jani AB; Master VA; Johnstone PA
    Radiother Oncol; 2009 Mar; 90(3):353-8. PubMed ID: 18952307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does intensity modulated radiation therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only?
    Guckenberger M; Baier K; Richter A; Vordermark D; Flentje M
    Radiat Oncol; 2008 Jan; 3():3. PubMed ID: 18190681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High accuracy of virtual simulation with the laser system Dorado CT4.
    Rades D; Frenzel T; Schwarz R; Walz J; Cremers F; Albers D; Alberti W; Schmidt R
    Strahlenther Onkol; 2007 Feb; 183(2):89-93. PubMed ID: 17294113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity-modulated radiotherapy of pelvic lymph nodes in locally advanced prostate cancer: planning procedures and early experiences.
    Muren LP; Wasbø E; Helle SI; Hysing LB; Karlsdottir A; Odland OH; Valen H; Ekerold R; Johannessen DC
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1034-41. PubMed ID: 18249502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.
    Arcangeli S; Saracino B; Petrongari MG; Gomellini S; Marzi S; Landoni V; Gallucci M; Sperduti I; Arcangeli G
    Radiother Oncol; 2007 Aug; 84(2):148-55. PubMed ID: 17692416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does pelvic lymph nodes irradiation using intensity modulated radiation therapy increase rectal and bladder toxicities in patients with prostate carcinoma?
    Garipagaoglu M; Sengoz M; Senkesen O; Ozan Göksel E; Tezcanli E; Kucucuk H; Aslay I
    J BUON; 2010; 15(4):668-73. PubMed ID: 21229627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G; Hancock SL; Boyer AL
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Planning for brachytherapy using a 3D-simulation model].
    Koizumi M; Inoue T; Inoue T; Yamazaki H; Kagawa K; Fukushima S; Matsumura S; Murayama S; Nose T; Tanaka E
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Jul; 55(8):603-5. PubMed ID: 7638059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the hypofractionated treatment of high-risk prostate cancer.
    Yuen J; Rodrigues G; Trenka K; Coad T; Yartsev S; D'Souza D; Lock M; Bauman G
    Radiat Oncol; 2008 Jan; 3():1. PubMed ID: 18179695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical aspects of inverse-planned intensity-modulated radiation therapy for prostate cancer: a radiation treatment planner's perspective.
    Parker W; Patrocinio H
    Can J Urol; 2005 Jun; 12 Suppl 2():48-52. PubMed ID: 16018834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
    Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
    Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of forward and inverse planned conformal, multi segment and intensity modulated radiotherapy for the treatment of prostate and pelvic nodes.
    Vaarkamp J; Adams EJ; Warrington AP; Dearnaley DP
    Radiother Oncol; 2004 Oct; 73(1):65-72. PubMed ID: 15465148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telematics enabled virtual simulation system for radiation treatment planning.
    Ntasis E; Gletsos M; Mouravliansky NA; Zacharaki EI; Vasios CE; Golemati S; Maniatis TA; Nikita KS
    Comput Biol Med; 2005 Nov; 35(9):765-81. PubMed ID: 16278107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual simulation: fifteen years later.
    Valentini V; Piermattei A; Morganti AG; Gambacorta MA; Azario L; Macchia G; Deodato F; Cilla S; Pepe D; Grimaldi L; Dinapoli N; Cellini N
    Rays; 2003; 28(3):293-8. PubMed ID: 15018316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET/CT and radiotherapy in prostate cancer.
    De Jong IJ; De Haan TD; Wiegman EM; Van Den Bergh AC; Pruim J; Breeuwsma AJ
    Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):543-52. PubMed ID: 20927021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.